https://www.europeanpharmaceuticalreview.com/news/183546/chikungunya-vaccine-demonstrates-99-percent-immune-response/
0
0
6/13/23 at 2:15pm
Organization
European Pharmaceutical Review
27 words
0
Comments
If approved, VLA1553 could become the first licensed chikungunya vaccine available to address this unmet medical need.
You are the first to view
Create an account
or login to join the discussion